LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells

LIM protein‐domain containing protein Ajuba (encoded by AJUBA) functions as a scaffold protein to regulate protein–protein interactions, signalling transduction and genes transcription. AJUBA expression is higher in colorectal cancer (CRC) tissues than normal tissues, but its specific molecular func...

Full description

Bibliographic Details
Main Authors: Beihui Xu, Qi Li, Jianjun Zhang, Fuxiang Chen
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.13421
_version_ 1797755328894337024
author Beihui Xu
Qi Li
Jianjun Zhang
Fuxiang Chen
author_facet Beihui Xu
Qi Li
Jianjun Zhang
Fuxiang Chen
author_sort Beihui Xu
collection DOAJ
description LIM protein‐domain containing protein Ajuba (encoded by AJUBA) functions as a scaffold protein to regulate protein–protein interactions, signalling transduction and genes transcription. AJUBA expression is higher in colorectal cancer (CRC) tissues than normal tissues, but its specific molecular function in CRC progression is still not very clear. Here, we found that, in CRC cancer cell lines, overexpression of AJUBA decreased p53 levels, whereas knock‐down of AJUBA significantly increased p53 levels. Although the presence of Ajuba did not influence p53 transcription, it formed a complex with p53 and MDM2 to promote the degradation of p53. AJUBA overexpression reduced the sensitivity of cancer cells to chemotherapeutic drugs and vice versa. In addition, chemotherapeutic drugs significantly induced AJUBA expression, which was largely dependent on the presence of p53. Therefore, Ajuba formed a negative feedback loop to regulate p53 expression and activity. In conclusion, as a novel p53‐negative regulator, Ajuba inhibits the apoptosis of CRC cells induced by chemotherapeutic drugs and it may be a new therapeutic target for CRC treatment.
first_indexed 2024-03-12T17:46:16Z
format Article
id doaj.art-163ce8851b96403aba8d6ffa897d48f4
institution Directory Open Access Journal
issn 1574-7891
1878-0261
language English
last_indexed 2024-03-12T17:46:16Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj.art-163ce8851b96403aba8d6ffa897d48f42023-08-03T16:44:15ZengWileyMolecular Oncology1574-78911878-02612023-08-011781678169110.1002/1878-0261.13421LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cellsBeihui Xu0Qi Li1Jianjun Zhang2Fuxiang Chen3Laboratory Medicine, Ninth People's Hospital Shanghai Jiao Tong University School of Medicine ChinaState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences ChinaDepartment of Oral and Maxillofacial‐Head & Neck Oncology, Ninth People's Hospital Shanghai Jiao Tong University School of Medicine ChinaLaboratory Medicine, Ninth People's Hospital Shanghai Jiao Tong University School of Medicine ChinaLIM protein‐domain containing protein Ajuba (encoded by AJUBA) functions as a scaffold protein to regulate protein–protein interactions, signalling transduction and genes transcription. AJUBA expression is higher in colorectal cancer (CRC) tissues than normal tissues, but its specific molecular function in CRC progression is still not very clear. Here, we found that, in CRC cancer cell lines, overexpression of AJUBA decreased p53 levels, whereas knock‐down of AJUBA significantly increased p53 levels. Although the presence of Ajuba did not influence p53 transcription, it formed a complex with p53 and MDM2 to promote the degradation of p53. AJUBA overexpression reduced the sensitivity of cancer cells to chemotherapeutic drugs and vice versa. In addition, chemotherapeutic drugs significantly induced AJUBA expression, which was largely dependent on the presence of p53. Therefore, Ajuba formed a negative feedback loop to regulate p53 expression and activity. In conclusion, as a novel p53‐negative regulator, Ajuba inhibits the apoptosis of CRC cells induced by chemotherapeutic drugs and it may be a new therapeutic target for CRC treatment.https://doi.org/10.1002/1878-0261.13421Ajubaapoptosischemoresistancecolorectal cancerp53
spellingShingle Beihui Xu
Qi Li
Jianjun Zhang
Fuxiang Chen
LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
Molecular Oncology
Ajuba
apoptosis
chemoresistance
colorectal cancer
p53
title LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
title_full LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
title_fullStr LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
title_full_unstemmed LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
title_short LIM domain‐containing protein Ajuba inhibits chemotherapy‐induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
title_sort lim domain containing protein ajuba inhibits chemotherapy induced apoptosis by negatively regulating p53 stability in colorectal cancer cells
topic Ajuba
apoptosis
chemoresistance
colorectal cancer
p53
url https://doi.org/10.1002/1878-0261.13421
work_keys_str_mv AT beihuixu limdomaincontainingproteinajubainhibitschemotherapyinducedapoptosisbynegativelyregulatingp53stabilityincolorectalcancercells
AT qili limdomaincontainingproteinajubainhibitschemotherapyinducedapoptosisbynegativelyregulatingp53stabilityincolorectalcancercells
AT jianjunzhang limdomaincontainingproteinajubainhibitschemotherapyinducedapoptosisbynegativelyregulatingp53stabilityincolorectalcancercells
AT fuxiangchen limdomaincontainingproteinajubainhibitschemotherapyinducedapoptosisbynegativelyregulatingp53stabilityincolorectalcancercells